Page last updated: 2024-12-10

sdz 216-525

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

SDZ 216-525: structure given in first source; a selective 5-HT(1A) receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3037456
SCHEMBL ID1041165
MeSH IDM0214781

Synonyms (21)

Synonym
gtpl78
sdz-216525
PDSP1_000565
PDSP2_000563
sdz 216-525
L006004
methyl 4-[4-[4-(1,1,3-trioxo-1,2-benzothiazol-2-yl)butyl]piperazin-1-yl]-1h-indole-2-carboxylate
141533-35-9
sdz-216-525
methyl 4-(4-(4-(1,1,3-trioxo-2h-1,2-benzoisothiazol-2-yl)butyl)-1-piperazinyl)-1h-indole-2-carboxylate
1h-indole-2-carboxylic acid, 4-(4-(4-(3-oxo-1,2-benzisothiazol-2(3h)-yl)butyl)-1-piperazinyl)-, methyl ester, s,s-dioxide
1h-indole-2-carboxylic acid, 4-(4-(4-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3h)-yl)butyl)-1-piperazinyl)-, methyl ester
sdz 216,525
cas_141533-35-9
bdbm82367
SCHEMBL1041165
sdz216-525
DTXSID10161757
methyl 4-(4-(4-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3h)-yl)butyl)piperazin-1-yl)-1h-indole-2-carboxylate
Q27088769
AKOS040749469

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"0 mg/kg) produced a behavioural profile indicative of an anxiolyticlike effect, with an apparent bell-shaped dose-response relationship and increases in nonexploratory behaviours at the largest dose tested."( Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190.
Cao, BJ; Rodgers, RJ, 1997
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID624215Antagonists at Human 5-Hydroxytryptamine receptor 5-HT1A1997Life sciences, , Volume: 60, Issue:9
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
AID1345615Human 5-HT1A receptor (5-Hydroxytryptamine receptors)1997Life sciences, , Volume: 60, Issue:9
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's13 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]